Dr Reddy’s Laboratories (DRL), which received permission from India’s drug regulator to import the Sputnik V vaccine, could potentially mop up around $300 million from its initial sales.from Business News: Latest News on Business, Stock Markets, Financial News, India Business & World Business News https://ift.tt/3x3Z8iK
